Global Patient Derived Xenograft/PDX Models Market Size, Status and Forecast 2024-2031

Report ID: 1013591 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Mice Models
        1.2.3 Rat Models
    1.3 Market by Application
        1.3.1 Global Patient Derived Xenograft/PDX Models Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Pre-clinical Drug Development and Basic Cancer Research
        1.3.3 Biomarker Analysis
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Patient Derived Xenograft/PDX Models Market Perspective (2016-2027)
    2.2 Patient Derived Xenograft/PDX Models Growth Trends by Regions
        2.2.1 Patient Derived Xenograft/PDX Models Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Patient Derived Xenograft/PDX Models Historic Market Share by Regions (2016-2021)
        2.2.3 Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2022-2027)
    2.3 Patient Derived Xenograft/PDX Models Industry Dynamic
        2.3.1 Patient Derived Xenograft/PDX Models Market Trends
        2.3.2 Patient Derived Xenograft/PDX Models Market Drivers
        2.3.3 Patient Derived Xenograft/PDX Models Market Challenges
        2.3.4 Patient Derived Xenograft/PDX Models Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue
        3.1.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue (2016-2021)
        3.1.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Players (2016-2021)
    3.2 Global Patient Derived Xenograft/PDX Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Patient Derived Xenograft/PDX Models Revenue
    3.4 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio
        3.4.1 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Patient Derived Xenograft/PDX Models Revenue in 2020
    3.5 Patient Derived Xenograft/PDX Models Key Players Head office and Area Served
    3.6 Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
    3.7 Date of Enter into Patient Derived Xenograft/PDX Models Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Patient Derived Xenograft/PDX Models Breakdown Data by Type
    4.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Type (2016-2021)
    4.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2022-2027)

5 Patient Derived Xenograft/PDX Models Breakdown Data by Application
    5.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Application (2016-2021)
    5.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Patient Derived Xenograft/PDX Models Market Size (2016-2027)
    6.2 North America Patient Derived Xenograft/PDX Models Market Size by Type
        6.2.1 North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
        6.2.2 North America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
        6.2.3 North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
    6.3 North America Patient Derived Xenograft/PDX Models Market Size by Application
        6.3.1 North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
        6.3.2 North America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
        6.3.3 North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
    6.4 North America Patient Derived Xenograft/PDX Models Market Size by Country
        6.4.1 North America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
        6.4.2 North America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Patient Derived Xenograft/PDX Models Market Size (2016-2027)
    7.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type
        7.2.1 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
        7.2.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
        7.2.3 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
    7.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application
        7.3.1 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
        7.3.2 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
        7.3.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
    7.4 Europe Patient Derived Xenograft/PDX Models Market Size by Country
        7.4.1 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
        7.4.2 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (2016-2027)
    8.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type
        8.2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
    8.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application
        8.3.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
    8.4 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region
        8.4.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Patient Derived Xenograft/PDX Models Market Size (2016-2027)
    9.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Type
        9.2.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
        9.2.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
        9.2.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
    9.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Application
        9.3.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
        9.3.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
        9.3.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
    9.4 Latin America Patient Derived Xenograft/PDX Models Market Size by Country
        9.4.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
        9.4.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size (2016-2027)
    10.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type
        10.2.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
    10.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application
        10.3.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
    10.4 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country
        10.4.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Crown Bioscience
        11.1.1 Crown Bioscience Company Details
        11.1.2 Crown Bioscience Business Overview
        11.1.3 Crown Bioscience Patient Derived Xenograft/PDX Models Introduction
        11.1.4 Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.1.5 Crown Bioscience Recent Development
    11.2 The Jackson Laboratory
        11.2.1 The Jackson Laboratory Company Details
        11.2.2 The Jackson Laboratory Business Overview
        11.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Introduction
        11.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.2.5 The Jackson Laboratory Recent Development
    11.3 Champions Oncology
        11.3.1 Champions Oncology Company Details
        11.3.2 Champions Oncology Business Overview
        11.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Introduction
        11.3.4 Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.3.5 Champions Oncology Recent Development
    11.4 Charles River Laboratories
        11.4.1 Charles River Laboratories Company Details
        11.4.2 Charles River Laboratories Business Overview
        11.4.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Introduction
        11.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.4.5 Charles River Laboratories Recent Development
    11.5 WuXi Apptec
        11.5.1 WuXi Apptec Company Details
        11.5.2 WuXi Apptec Business Overview
        11.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Introduction
        11.5.4 WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.5.5 WuXi Apptec Recent Development
    11.6 Oncodesign
        11.6.1 Oncodesign Company Details
        11.6.2 Oncodesign Business Overview
        11.6.3 Oncodesign Patient Derived Xenograft/PDX Models Introduction
        11.6.4 Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.6.5 Oncodesign Recent Development
    11.7 Horizon Discovery
        11.7.1 Horizon Discovery Company Details
        11.7.2 Horizon Discovery Business Overview
        11.7.3 Horizon Discovery Patient Derived Xenograft/PDX Models Introduction
        11.7.4 Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.7.5 Horizon Discovery Recent Development
    11.8 Pharmatest Services
        11.8.1 Pharmatest Services Company Details
        11.8.2 Pharmatest Services Business Overview
        11.8.3 Pharmatest Services Patient Derived Xenograft/PDX Models Introduction
        11.8.4 Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.8.5 Pharmatest Services Recent Development
    11.9 Hera Biolabs
        11.9.1 Hera Biolabs Company Details
        11.9.2 Hera Biolabs Business Overview
        11.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Introduction
        11.9.4 Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.9.5 Hera Biolabs Recent Development
    11.10 EPO Berlin-Buch
        11.10.1 EPO Berlin-Buch Company Details
        11.10.2 EPO Berlin-Buch Business Overview
        11.10.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Introduction
        11.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.10.5 EPO Berlin-Buch Recent Development
    11.11 Xentech
        11.11.1 Xentech Company Details
        11.11.2 Xentech Business Overview
        11.11.3 Xentech Patient Derived Xenograft/PDX Models Introduction
        11.11.4 Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.11.5 Xentech Recent Development
    11.12 Urolead
        11.12.1 Urolead Company Details
        11.12.2 Urolead Business Overview
        11.12.3 Urolead Patient Derived Xenograft/PDX Models Introduction
        11.12.4 Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
        11.12.5 Urolead Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Mice Models
    Table 3. Key Players of Rat Models
    Table 4. Global Patient Derived Xenograft/PDX Models Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Patient Derived Xenograft/PDX Models Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Patient Derived Xenograft/PDX Models Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2016-2021)
    Table 8. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2022-2027)
    Table 10. Patient Derived Xenograft/PDX Models Market Trends
    Table 11. Patient Derived Xenograft/PDX Models Market Drivers
    Table 12. Patient Derived Xenograft/PDX Models Market Challenges
    Table 13. Patient Derived Xenograft/PDX Models Market Restraints
    Table 14. Global Patient Derived Xenograft/PDX Models Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Patient Derived Xenograft/PDX Models Market Share by Players (2016-2021)
    Table 16. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2020)
    Table 17. Ranking of Global Top Patient Derived Xenograft/PDX Models Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Patient Derived Xenograft/PDX Models Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
    Table 21. Date of Enter into Patient Derived Xenograft/PDX Models Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2016-2021)
    Table 25. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2016-2021)
    Table 29. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Crown Bioscience Company Details
    Table 62. Crown Bioscience Business Overview
    Table 63. Crown Bioscience Patient Derived Xenograft/PDX Models Product
    Table 64. Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 65. Crown Bioscience Recent Development
    Table 66. The Jackson Laboratory Company Details
    Table 67. The Jackson Laboratory Business Overview
    Table 68. The Jackson Laboratory Patient Derived Xenograft/PDX Models Product
    Table 69. The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 70. The Jackson Laboratory Recent Development
    Table 71. Champions Oncology Company Details
    Table 72. Champions Oncology Business Overview
    Table 73. Champions Oncology Patient Derived Xenograft/PDX Models Product
    Table 74. Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 75. Champions Oncology Recent Development
    Table 76. Charles River Laboratories Company Details
    Table 77. Charles River Laboratories Business Overview
    Table 78. Charles River Laboratories Patient Derived Xenograft/PDX Models Product
    Table 79. Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 80. Charles River Laboratories Recent Development
    Table 81. WuXi Apptec Company Details
    Table 82. WuXi Apptec Business Overview
    Table 83. WuXi Apptec Patient Derived Xenograft/PDX Models Product
    Table 84. WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 85. WuXi Apptec Recent Development
    Table 86. Oncodesign Company Details
    Table 87. Oncodesign Business Overview
    Table 88. Oncodesign Patient Derived Xenograft/PDX Models Product
    Table 89. Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 90. Oncodesign Recent Development
    Table 91. Horizon Discovery Company Details
    Table 92. Horizon Discovery Business Overview
    Table 93. Horizon Discovery Patient Derived Xenograft/PDX Models Product
    Table 94. Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 95. Horizon Discovery Recent Development
    Table 96. Pharmatest Services Company Details
    Table 97. Pharmatest Services Business Overview
    Table 98. Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 99. Pharmatest Services Recent Development
    Table 100. Hera Biolabs Company Details
    Table 101. Hera Biolabs Business Overview
    Table 102. Hera Biolabs Patient Derived Xenograft/PDX Models Product
    Table 103. Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 104. Hera Biolabs Recent Development
    Table 105. EPO Berlin-Buch Company Details
    Table 106. EPO Berlin-Buch Business Overview
    Table 107. EPO Berlin-Buch Patient Derived Xenograft/PDX Models Product
    Table 108. EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 109. EPO Berlin-Buch Recent Development
    Table 110. Xentech Company Details
    Table 111. Xentech Business Overview
    Table 112. Xentech Patient Derived Xenograft/PDX Models Product
    Table 113. Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 114. Xentech Recent Development
    Table 115. Urolead Company Details
    Table 116. Urolead Business Overview
    Table 117. Urolead Patient Derived Xenograft/PDX Models Product
    Table 118. Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
    Table 119. Urolead Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Patient Derived Xenograft/PDX Models Market Share by Type: 2020 VS 2027
    Figure 2. Mice Models Features
    Figure 3. Rat Models Features
    Figure 4. Global Patient Derived Xenograft/PDX Models Market Share by Application: 2020 VS 2027
    Figure 5. Pre-clinical Drug Development and Basic Cancer Research Case Studies
    Figure 6. Biomarker Analysis Case Studies
    Figure 7. Patient Derived Xenograft/PDX Models Report Years Considered
    Figure 8. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Patient Derived Xenograft/PDX Models Market Share by Regions: 2020 VS 2027
    Figure 11. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2022-2027)
    Figure 12. Global Patient Derived Xenograft/PDX Models Market Share by Players in 2020
    Figure 13. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Patient Derived Xenograft/PDX Models Revenue in 2020
    Figure 15. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2016-2021)
    Figure 16. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2022-2027)
    Figure 17. North America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
    Figure 19. North America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
    Figure 20. North America Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
    Figure 21. United States Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
    Figure 25. Europe Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
    Figure 26. Europe Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
    Figure 27. Germany Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Region (2016-2027)
    Figure 37. China Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
    Figure 45. Latin America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
    Figure 46. Latin America Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
    Figure 47. Mexico Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
    Figure 53. Turkey Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Crown Bioscience Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 57. The Jackson Laboratory Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 58. Champions Oncology Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 59. Charles River Laboratories Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 60. WuXi Apptec Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 61. Oncodesign Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 62. Horizon Discovery Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 63. Pharmatest Services Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 64. Hera Biolabs Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 65. EPO Berlin-Buch Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 66. Xentech Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 67. Urolead Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch
Xentech
Urolead
Frequently Asked Questions
Patient Derived Xenograft/PDX Models report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Patient Derived Xenograft/PDX Models report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Patient Derived Xenograft/PDX Models report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports